These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39333070)

  • 1. Cryo-EM structure of small-molecule agonist bound delta opioid receptor-G
    Cheng L; Miao Z; Liu S; Li Z; Fu H; Xu C; Hu S; Zhao C; Liu Y; Zhao T; Liu W; Wang H; Liu R; Yan W; Tang X; Liu J; Shao Z; Ke B
    Nat Commun; 2024 Sep; 15(1):8284. PubMed ID: 39333070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
    Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
    Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities.
    Meqbil YJ; Su H; Cassell RJ; Mores KL; Gutridge AM; Cummins BR; Chen L; van Rijn RM
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel
    Meqbil YJ; Aguilar J; Blaine AT; Chen L; Cassell RJ; Pradhan AA; van Rijn RM
    J Pharmacol Exp Ther; 2024 May; 389(3):301-309. PubMed ID: 38621994
    [No Abstract]   [Full Text] [Related]  

  • 5. The Meta-Position of Phe
    Cassell RJ; Sharma KK; Su H; Cummins BR; Cui H; Mores KL; Blaine AT; Altman RA; van Rijn RM
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31842282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
    Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures.
    Blaine AT; van Rijn RM
    Neuropharmacology; 2023 Jul; 232():109526. PubMed ID: 37004753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.
    Hong MH; Xu C; Wang YJ; Ji JL; Tao YM; Xu XJ; Chen J; Xie X; Chi ZQ; Liu JG
    J Neurochem; 2009 Jan; 108(1):102-14. PubMed ID: 19014372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways.
    Karasawa Y; Miyano K; Fujii H; Mizuguchi T; Kuroda Y; Nonaka M; Komatsu A; Ohshima K; Yamaguchi M; Yamaguchi K; Iseki M; Uezono Y; Hayashida M
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryo-EM Structure of the Human Cannabinoid Receptor CB2-G
    Xing C; Zhuang Y; Xu TH; Feng Z; Zhou XE; Chen M; Wang L; Meng X; Xue Y; Wang J; Liu H; McGuire TF; Zhao G; Melcher K; Zhang C; Xu HE; Xie XQ
    Cell; 2020 Feb; 180(4):645-654.e13. PubMed ID: 32004460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel G Protein-Biased Agonist at the
    Conibear AE; Asghar J; Hill R; Henderson G; Borbely E; Tekus V; Helyes Z; Palandri J; Bailey C; Starke I; von Mentzer B; Kendall D; Kelly E
    J Pharmacol Exp Ther; 2020 Feb; 372(2):224-236. PubMed ID: 31594792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.
    Lu JJ; Polgar WE; Mann A; Dasgupta P; Schulz S; Zaveri NT
    Mol Pharmacol; 2021 Jul; 100(1):7-18. PubMed ID: 33958480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.
    Nijmeijer S; Vischer HF; Sirci F; Schultes S; Engelhardt H; de Graaf C; Rosethorne EM; Charlton SJ; Leurs R
    Br J Pharmacol; 2013 Sep; 170(1):78-88. PubMed ID: 23351115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and β-arrestin 1 pathway.
    Mittal N; Roberts K; Pal K; Bentolila LA; Fultz E; Minasyan A; Cahill C; Pradhan A; Conner D; DeFea K; Evans C; Walwyn W
    Cell Rep; 2013 Nov; 5(4):1010-21. PubMed ID: 24239352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-Specific Recruitment of Arrestin Isoforms Differentially Modify Delta Opioid Receptor Function.
    Pradhan AA; Perroy J; Walwyn WM; Smith ML; Vicente-Sanchez A; Segura L; Bana A; Kieffer BL; Evans CJ
    J Neurosci; 2016 Mar; 36(12):3541-51. PubMed ID: 27013682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake.
    Chiang T; Sansuk K; van Rijn RM
    Br J Pharmacol; 2016 Jan; 173(2):332-43. PubMed ID: 26507558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists.
    Audet N; Charfi I; Mnie-Filali O; Amraei M; Chabot-Doré AJ; Millecamps M; Stone LS; Pineyro G
    J Neurosci; 2012 Apr; 32(14):4827-40. PubMed ID: 22492038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias.
    Pineyro G; Nagi K
    Cell Signal; 2021 Apr; 80():109906. PubMed ID: 33383156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.
    Pradhan AA; Walwyn W; Nozaki C; Filliol D; Erbs E; Matifas A; Evans C; Kieffer BL
    J Neurosci; 2010 Dec; 30(49):16459-68. PubMed ID: 21147985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.
    Rozenfeld R; Devi LA
    FASEB J; 2007 Aug; 21(10):2455-65. PubMed ID: 17384143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.